Study did not meet primary endpoint of complete healing of PCED at Week 8; secondary endpoints also did not achieve ...
Ataraxis AI, a frontier laboratory developing artificial intelligence (AI)–powered prognostic tools for oncology, and MEDSIR ...
Most patients receiving chemotherapy with taxanes or platinum salts develop pain and loss of sensitivity in their hands and ...
3don MSN
Motivational support and text messages boost proper child car seat use, clinical trial finds
Parents improved their use of appropriate child car seats after remote motivational counseling and mobile-based support, ...
Results from a randomised clinical trial (RCT) look at the use of Memantine to treat social impairment in young people with autism. Professor Ian Maidment, Professor in Clinical Pharmacy, Aston ...
Parents improved use of appropriate child car seats after remote motivational counseling and mobile-based support, according to the results from a randomized clinical trial published in JAMA Network ...
News-Medical.Net on MSN
Remote motivational counseling and mobile-based support help parents use safer car seats
Parents improved use of appropriate child car seats after remote motivational counseling and mobile-based support, according ...
Verywell Health on MSN
What Happens to Your Cholesterol When You Take Calcium Supplements
Calcium supports bone health and other bodily functions, but some evidence suggests it can have cholesterol-lowering effects, too.
News-Medical.Net on MSN
Randomized trial shows exercise benefits for post-COVID immune regulation
Exercise can help to restore a more normal, well-regulated immune system in people with post-COVID syndrome, according to a ...
The 2019 study, published in Prehospital Emergency Care and led by Dr. Gina Agarwal of McMaster University, was the first large multi-site randomized controlled trial of its kind in North ...
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi has launched a Phase 3 clinical study titled A Multicenter, ...
Symptomatic or viral rebound is estimated to occur in 0.8% to 32% of Paxlovid recipients and 1.1% to 31% of those who receive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results